| 发明名称 |
Treatment of attention disorders |
| 摘要 |
The invention provides methods and medicaments for improving attentiveness in humans, including subjects diagnosed with attention disorders. In one aspect, a GABA<SUB>B </SUB>receptor antagonist, such as 3-aminopropyl-(n-butyl)-phosphinic acid (ABPA), is used to improve attention.
|
| 申请公布号 |
US2005187196(A1) |
申请公布日期 |
2005.08.25 |
| 申请号 |
US20050064887 |
申请日期 |
2005.02.23 |
| 申请人 |
SAEGIS PHARMACEUTICALS, INC. |
发明人 |
MADRID ANNETTE;JENKINS HELEN;PEARLMAN RODNEY |
| 分类号 |
A61K31/137;A61K31/445;A61K31/66;(IPC1-7):A61K31/66 |
主分类号 |
A61K31/137 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
